Back
Viking Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
28
VKTX
Viking Therapeutics
Last Price:
38.24
Seasonality Move:
40.87%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
Viking Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.82 | Sell |
| 20-day SMA: | 49.84 | Sell |
| 50-day SMA: | 58.67 | Sell |
| 200-day SMA: | 62.24 | Sell |
| 8-day EMA: | 46.02 | Sell |
| 20-day EMA: | 49.86 | Sell |
| 50-day EMA: | 55.23 | Sell |
| 200-day EMA: | 54.61 | Sell |
Viking Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.91 | Sell |
| Relative Strength Index (14 RSI): | 23.24 | Sell |
| Chaikin Money Flow: | -10764092 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.91 - 53.55) | Sell |
| Bollinger Bands (100): | (52.21 - 67.17) | Sell |
Viking Therapeutics Technical Analysis
| Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 38.28 while VKTX 8-day simple moving average is 46.82, which is a Sell signal.
- The stock price of VKTX is 38.28 while Viking Therapeutics 20-day SMA is 49.84, which makes it a Sell.
- Viking Therapeutics 50-day simple moving average is 58.67 while VKTX share price is 38.28, making it a Sell technically.
- VKTX stock price is 38.28 and Viking Therapeutics 200-day simple moving average is 62.24, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
28
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Sell
The current Viking Therapeutics [VKTX] share price is $38.28. The Score for VKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
4.27B
Price in USD:
38.28
Share Volume:
12.92M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
17.23
Sell
28
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?
The Viking Therapeutics stock price is 38.28 USD today. -
Will VKTX stock go up or go down?
Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viking Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 38.28 while VKTX 8-day exponential moving average is 46.02, which is a Sell signal.
- The stock price of VKTX is 38.28 while Viking Therapeutics 20-day EMA is 49.86, which makes it a Sell.
- Viking Therapeutics 50-day exponential moving average is 55.23 while VKTX share price is 38.28, making it a Sell technically.
- VKTX stock price is 38.28 and Viking Therapeutics 200-day simple moving average is 54.61, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
- VKTX Moving Average Covergence Divergence (MACD) indicator is -3.91, suggesting Viking Therapeutics is a Sell
- Viking Therapeutics Relative Strength Index (RSI) is 23.24, which suggest Viking Therapeutics is oversold
- The Bollinger Bands (25) for Viking Therapeutics is (46.91 - 53.55), which suggest Viking Therapeutics is a Sell
- The Bollinger Bands (100) for Viking Therapeutics is (52.21 - 67.17), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.